Dividend / buyback / bonusNotableFiled on BSE ·

Global Health Ltd announces Q1 FY 2026-27 financial results and management changes

Global Health · Healthcare Services

Arthneeti Research DeskPublished 1 min read
₹1,079 CrDividend / buyback / bonus

Key highlights

  • Q1 June 30, 2026 standalone revenue ₹1,078.7 crore; profit after tax ₹137.3 crore; consolidated revenue ₹1,304 crore; PAT ₹157.3 crore
  • Appointed Mr. Pradeep Kumar Singh as Chief Digital Officer and Senior Management Personnel effective July 30, 2026
  • Approved revised hospital construction at Guwahati increasing bed capacity from 400 to 650 beds

Why it's rated notable: the amount is 21% of annual revenue (20% to 50%)

Figures checked against the filing by a second AI read. About the business, not the share price.

Original filing

Announcement under Regulation 30 (LODR)-Date of payment of Dividend

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Global Health

Other dividend / buyback / bonus filings this fortnight

All dividend / buyback / bonus filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.